Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

9 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

Phase 4
8(47.1%)
N/A
7(41.2%)
Phase 2
1(5.9%)
Phase 3
1(5.9%)
17Total
Phase 4(8)
N/A(7)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT07437573Phase 3Completed

Oncometabolic Surgery

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT03475498Recruiting

A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome)

Role: collaborator

NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT04719936Not ApplicableCompleted

Superior and Inferior Capsulotomy in Bipolar Hemiarthroplasty Using Posterior Approach

Role: collaborator

NCT02619994Phase 2Completed

Treatment Shortening of MDR-TB Using Existing and New Drugs

Role: collaborator

NCT06559202Completed

Inguinal and Axillary LN Size Distribution

Role: collaborator

NCT01895933Not ApplicableCompleted

Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel

Role: collaborator

NCT03683485Not ApplicableUnknown

Long-duration EPBD vs EST for Removal of Biliary Stones

Role: lead

NCT02580474Phase 4Completed

The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure

Role: collaborator

NCT02475824Phase 4Completed

Midazolam With Meperidine and Dexmedetomidine vs. Midazolam With Meperidine and Propofol for Sedation During ERCP

Role: lead

NCT02180568Not ApplicableCompleted

Lipiodol Localization for Ground-glass-opacity Minimal Surgery

Role: collaborator

NCT03375528Not ApplicableUnknown

Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation

Role: lead

NCT01902238Not ApplicableUnknown

EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study

Role: collaborator

NCT02308891Not ApplicableCompleted

A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis

Role: lead

NCT01127100Phase 4Completed

Gabapentin Versus Transdermal Fentanyl Matrix for Chronic Neuropathic Pain

Role: collaborator

NCT02364466Unknown

Cohort of Peripheral T Cell Lymphoma

Role: collaborator

NCT01903902Phase 4Unknown

Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries

Role: collaborator

NCT01871792Phase 4Unknown

Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction

Role: collaborator

NCT01365572Phase 4Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )

Role: collaborator